Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.
about
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.
@ast
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.
@en
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.
@nl
type
label
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.
@ast
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.
@en
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.
@nl
prefLabel
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.
@ast
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.
@en
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.
@nl
P2860
P50
P1476
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.
@en
P2860
P304
P356
10.1080/17512433.2016.1221760
P407
P577
2016-08-06T00:00:00Z